Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Total Non-Current Liabilities (2018 - 2025)

Neurogene's Total Non-Current Liabilities history spans 5 years, with the latest figure at $23.3 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities fell 5.47% year-over-year to $23.3 million; the TTM value through Dec 2025 reached $23.3 million, down 5.47%, while the annual FY2025 figure was $23.3 million, 5.47% down from the prior year.
  • Total Non-Current Liabilities reached $23.3 million in Q4 2025 per NGNE's latest filing, up from $21.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $35.5 million in Q4 2023 to a low of $21.9 million in Q3 2025.
  • Average Total Non-Current Liabilities over 3 years is $25.3 million, with a median of $24.4 million recorded in 2024.
  • Peak YoY movement for Total Non-Current Liabilities: crashed 30.68% in 2024, then decreased 3.02% in 2025.
  • A 3-year view of Total Non-Current Liabilities shows it stood at $35.5 million in 2023, then crashed by 30.68% to $24.6 million in 2024, then decreased by 5.47% to $23.3 million in 2025.
  • Per Business Quant, the three most recent readings for NGNE's Total Non-Current Liabilities are $23.3 million (Q4 2025), $21.9 million (Q3 2025), and $24.0 million (Q2 2025).